Fmr LLC Apellis Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 18,503 shares of APLS stock, worth $376,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,503

Previous 19,292 4.09%

Holding current value

$376,165

Previous $333,000 25.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$17.42 - $28.65 $13,744 - $22,604	-789 Reduced 4.09%	18,503 $418,000
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $24.3 Million - $34.1 Million	-1,483,917 Reduced 98.72%	19,292 $333,000
Q1 2025 May 12, 2025	SELL	$21.87 - $34.63 $13.7 Million - $21.6 Million	-624,456 Reduced 29.35%	1,503,209 $32.9 Million
Q4 2024 Feb 13, 2025	SELL	$26.18 - $35.42 $20.2 Million - $27.4 Million	-772,589 Reduced 26.64%	2,127,665 $67.9 Million
Q3 2024 Nov 13, 2024	SELL	$28.84 - $41.15 $11.5 Million - $16.4 Million	-399,536 Reduced 12.11%	2,900,254 $83.6 Million

Q2 2024 Aug 13, 2024	BUY	$38.07 - $59.71 $42.7 Million - $66.9 Million	1,121,048 Added 51.45%	3,299,790 $127 Million
Q1 2024 May 13, 2024	BUY	$55.39 - $72.47 $4.78 Million - $6.25 Million	86,278 Added 4.12%	2,178,742 $128 Million
Q4 2023 Feb 13, 2024	SELL	$37.14 - $64.82 $6.21 Million - $10.8 Million	-167,302 Reduced 7.4%	2,092,464 $125 Million
Q3 2023 Nov 13, 2023	SELL	$23.65 - $89.22 $46.5 Million - $175 Million	-1,965,829 Reduced 46.52%	2,259,766 $86 Million
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $161 Million - $196 Million	2,100,158 Added 98.81%	4,225,595 $385 Million
Q1 2023 May 11, 2023	BUY	$46.59 - $66.96 $31 Million - $44.5 Million	665,274 Added 45.56%	2,125,437 $140 Million
Q4 2022 Feb 13, 2023	SELL	$43.24 - $61.04 $43 - $61	-1 Reduced -0.0%	1,460,163 $75.5 Million
Q3 2022 Nov 10, 2022	BUY	$44.76 - $69.66 $3.21 Million - $5 Million	71,737 Added 5.17%	1,460,164 $99.7 Million
Q2 2022 Aug 12, 2022	SELL	$35.07 - $59.21 $321,416 - $542,659	-9,165 Reduced 0.66%	1,388,427 $62.8 Million
Q1 2022 May 13, 2022	SELL	$35.46 - $54.12 $7.7 Million - $11.8 Million	-217,267 Reduced 13.45%	1,397,592 $71 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $4.51 Million - $10 Million	143,694 Added 9.77%	1,614,859 $53.2 Million
Q2 2021 Aug 13, 2021	BUY	$40.9 - $64.9 $60.2 Million - $95.5 Million	1,471,165 New	1,471,165 $93 Million

Others Institutions Holding APLS

# of Institutions

331

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account